(Q34536159)

2 August 2017

1 reference

title

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants (English)

1 reference

2 August 2017

1 reference

1 reference

1 reference

Funk ML

1

1 reference

2 August 2017

Rosenberg DM

series ordinal

2

1 reference

2 August 2017

Lok AS

series ordinal

3

1 reference

2 August 2017

publication date

1 January 2002

1 reference

Journal of Viral Hepatitis

2 August 2017

published in

1 reference

2 August 2017

volume

9

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

52-61

1 reference

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Detection of hepatitis B virus precore stop codon mutants by selective amplification method: frequent detection of precore mutants in hepatitis B e antigen positive healthy carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Prevalence of precore‐defective mutant of hepatitis B virus in HBV carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Quantitative analysis of hepatitis B virus precore mutant in hepatitis type B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Anti-HBe titre in patients infected with wild-type and e-minus variant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Frequency of hepatitis B virus e-minus mutants varies among patients from different areas of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Mutations in the pre-core region of hepatitis B virus DNA in patients with chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Hepatitis B virus strains in Thailand: genomic variants in chronic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Nucleotide sequence of precore region of hepatitis B virus DNA in HBsAg-positive carriers in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Analysis of hepatitis B precore region in serum and liver of chronic hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Polymorphism of precore region of hepatitis B virus DNA among patients with chronic HBV infection in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Variations of hepatitis B virus core gene sequence in Western patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Clinical relevance of mutations in the precore genome of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. French Multicentre Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

The value of quantiative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00304.X

10.1046/J.1365-2893.2002.00304.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference